-
In "The Success Equation," Legg Mason Chief Investment Strategist Michael Mauboussin explores the role of skill and -- especially -- of luck in business, investing, sports, and life. Read More...
-
I am a member of the Mumbai Angels network , and I attended an interesting session on impact investing which Sasha Mirchandani organized . This gave me the chance to meet Charly Kleissner , who has pioneered the concept all across the world, through his Toniic Foundation . Indian culture has always placed...
-
I am a strategic angel investor in four healthcare startups. I invest in these because I think there is a huge opportunity to fix a sick healthcare system in India today ; and that clever entrepreneurs who run startups are in the best position to be able to provide these solutions. I'm happy to invest...
-
Michael Arrington’s recently announced decision to jump from journalist to investor (journovesting?) may have raised eyebrows in some circles (more from traditional media than new media, according to this interesting recent commentary), but he’s hardly the first reporter to leap into the arena. Especially...
Posted to
News
by
Health. Care.
on
Fri, Sep 9 2011
Filed under:
Filed under: google, byline=David Shaywitz, Business, Investing, New York Times, Morgan Stanley, Sequoia Capital, lazard, Tech, Millennium Technology Ventures, hedge fund, Fortune, Alsop Louie Partners, Media & Entertainment, Michael Moritz, WSJ, yahoo, TechCrunch, Alfred Winslow Jones
-
Banks respond to Vickers report over ringfencing Forcing banks to ringfence their high street operations from riskier investment banking – the so-called "casino banks" – is unnecessary and could have a detrimental impact on the economy, the banking industry has warned. The warnings came in...
Posted to
News
by
Latest financial, market & economic news and analysis | guardian.co.uk
on
Wed, Jul 13 2011
Filed under:
Filed under: news, Business, The Guardian, Virgin Group, Barclays, Lloyds Banking Group, Investing, Banco Santander, Banking, George Osborne, HSBC, Royal Bank of Scotland
-
Yup, we can’t get away from it anywhere we go in healthcare, as insurers and everyone else lives and dies by the algorithms of cost. When compared to non profits the number of cancer patients seen by for profits seemed dwarfed when compared. As the article states, Medicare pays $143 a day...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Feb 1 2011
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, Surgery, medicare, Budgets, Nursing Homes, Seniors, Investing, Hospice, Patients, Non Profit, General Accounting Office, for profit, private equity
-
The AGO prepared one report already and is working on a second report to ensure safety and care for seniors and they were overly concerned over the lack of data and information provided to make a full evaluation. We had one case in California that turned pretty ugly with patients not getting adequate...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Nov 26 2010
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, Surgery, medicare, Budgets, Nursing Homes, Seniors, Investing, Patients, General Accounting Office, private equity
-
This is done very well in Jon Stewart style and worth a listen. We all know what happened and what continues to happen and they don’t come out and say it, but it’s “those algorithms” once more that make big bucks! This is pretty funny on some of the points they hit on. The authors...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Nov 18 2010
Filed under:
Filed under: Other Items of Interest, My Commentaries, Gambling, Anger, Journalism, Investing, Wall Street, Algorithms, hedge funds, Daily Show, Jon Stewart, financial crisis
-
If you did not see this on 60 Minutes this week, take a look and get educated on how fast things are moving today. Keep in mind we are insured for our healthcare with companies living right within the community too. When a healthcare claim is filed, it’s going through technological motions...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Oct 12 2010
Filed under:
Filed under: Technology, Other Items of Interest, My Commentaries, healthcare, Investing, Wall Street, transactions, High Frequency Healthcare, algoirthms, High Frequency Trading
-
We talk about super computing on Wall Street and I mention occasionally how this technology slips over to healthcare and here’s one prime example. Obviously with risk management with health insurers, this would appear to be a company they would consider watching. Already major pharma companies...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Apr 27 2010
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, drugs, healthcare, Pharma, clinical trials, Congress, Pfizer, Johnson and Johnson, Investing, Wall Street, Patients, pharmacy benefit managers, High Frequency Healthcare, Gene Network Sciences, GNS, PBM
-
It appears we will have some insight with which US firms have money in Swiss banks, or at least one of the banks. What is even more interesting here is that in the last couple of weeks, UBS competitor , Jeffries stole most of the healthcare bankers. “Last month, Jefferies hired away...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Aug 2 2009
Filed under:
Filed under: Medically Related, Other Items of Interest, IRS, Heatlhcare, Investing, Banking, Switzerland, UBS, Jeffries, tax evasion
-
39 Generic Drugs to be sold in the US, and 12 injectable drugs are part of the deal. Pfizer is not alone, other pharma companies are doing the same as drug patents are getting closer to expiring. In the meantime, we have this inquiry going on over at Harvard. It looks like it’s getting...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Mar 4 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Biotech, Generic Drugs, Pharmaceuticals, Pfizer, China, India, Investing, Harvard Medical Center
-
As promised, Scott Hensley with Fox News on what the buy out means. It discusses the investment portions as well as the expense and difficulty today in bringing new products to market. Lipitor, is due to come off patent and they need more in the pipeline and the birthplace factory for Lipitor...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jan 26 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Biotech, FDA, Science, Pharmaceuticals, Wyeth, Pfizer, Investing, Investments, Fox News, WSJ, Buyout, WSJ healthcare blog
-
A great interview from Robert Scoble, sit down and watch when you have time to listen to all. Does healthcare enter here, you bet. Do we want the government to stay in the dark ages? Maybe, as they might spy on us, but we don't mind Google and Microsoft doing it...does the government...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Sep 3 2008
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, healthcare, Fedex, Government, Politics, Economics, Judy Estrin, Investing, Disney, Wall Street, Robert Scoble, generations